Atrial Fibrillation: Inflammation in Disguise?
Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and thrombo‐embolism. Over the past years, there has been increasing interest in the role of inflammatory processes in atrial fibrillation, from the first occ...
Gespeichert in:
| Veröffentlicht in: | Scandinavian journal of immunology 2013-08, Vol.78 (2), p.112-119 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 119 |
|---|---|
| container_issue | 2 |
| container_start_page | 112 |
| container_title | Scandinavian journal of immunology |
| container_volume | 78 |
| creator | Lappegård, K. T. Hovland, A. Pop, G. A. M. Mollnes, T. E. |
| description | Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and thrombo‐embolism. Over the past years, there has been increasing interest in the role of inflammatory processes in atrial fibrillation, from the first occurrence of the arrhythmia to dreaded complications such as strokes or peripheral emboli. As the standard drug combination which aims at rate control and anticoagulation only offers partial protection against complications, newer agents are needed to optimize treatment. In this paper, we review recent knowledge regarding the impact of inflammation on the occurrence, recurrence, perpetuation and complications of the arrhythmia, as well as the role of anti‐inflammatory therapies in the treatment for the disease. |
| doi_str_mv | 10.1111/sji.12061 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1419372869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1411635322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4521-a2658329b5d7a7f4efc5e006f04bbdd2a5ab38f441ce856d2e3b4eeded5730aa3</originalsourceid><addsrcrecordid>eNqN0MtKAzEUBuAgiq3VhS8gA250MW2Sk8uMGynVaqXgQl2HzExGUuaiSQfp2xs71YUgmM0h8PFzzo_QKcFjEt7Er-yYUCzIHhoSEDwGnMA-GmLAOE6Z5AN05P0KYwJUwiEaUBCSMsBDNJ6undVVNLeZs1Wl17ZtrqJFU1a6rre_yDbRjfWvnfXm-hgdlLry5mQ3R-hlfvs8u4-Xj3eL2XQZ54xTEmsqeAI0zXghtSyZKXNuMBYlZllWFFRznUFSMkZyk3BRUAMZM6YwBZeAtYYRuuhz31z73hm_VrX1uQkLNqbtvCKMpCBpItL_UCKAA6WBnv-iq7ZzTTgkKCoTnpKEB3XZq9y13jtTqjdna-02imD11bcKfatt38Ge7RK7rDbFj_wuOIBJDz5sZTZ_J6mnh0Uf-QnHKIdJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1427859185</pqid></control><display><type>article</type><title>Atrial Fibrillation: Inflammation in Disguise?</title><source>MEDLINE</source><source>Wiley Free Content</source><source>IngentaConnect Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Lappegård, K. T. ; Hovland, A. ; Pop, G. A. M. ; Mollnes, T. E.</creator><creatorcontrib>Lappegård, K. T. ; Hovland, A. ; Pop, G. A. M. ; Mollnes, T. E.</creatorcontrib><description>Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and thrombo‐embolism. Over the past years, there has been increasing interest in the role of inflammatory processes in atrial fibrillation, from the first occurrence of the arrhythmia to dreaded complications such as strokes or peripheral emboli. As the standard drug combination which aims at rate control and anticoagulation only offers partial protection against complications, newer agents are needed to optimize treatment. In this paper, we review recent knowledge regarding the impact of inflammation on the occurrence, recurrence, perpetuation and complications of the arrhythmia, as well as the role of anti‐inflammatory therapies in the treatment for the disease.</description><identifier>ISSN: 0300-9475</identifier><identifier>EISSN: 1365-3083</identifier><identifier>DOI: 10.1111/sji.12061</identifier><identifier>PMID: 23672430</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Animals ; Anti-Arrhythmia Agents - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Anticoagulants - therapeutic use ; Arrhythmias, Cardiac - drug therapy ; Arrhythmias, Cardiac - etiology ; Arrhythmias, Cardiac - physiopathology ; Atrial Fibrillation - complications ; Atrial Fibrillation - drug therapy ; Atrial Fibrillation - physiopathology ; Heart Failure - drug therapy ; Heart Failure - etiology ; Heart Failure - physiopathology ; Humans ; Inflammation - drug therapy ; Stroke - drug therapy ; Stroke - etiology ; Stroke - physiopathology ; Thromboembolism - drug therapy ; Thromboembolism - etiology ; Thromboembolism - physiopathology</subject><ispartof>Scandinavian journal of immunology, 2013-08, Vol.78 (2), p.112-119</ispartof><rights>2013 John Wiley & Sons Ltd</rights><rights>2013 John Wiley & Sons Ltd.</rights><rights>Copyright © 2013 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4521-a2658329b5d7a7f4efc5e006f04bbdd2a5ab38f441ce856d2e3b4eeded5730aa3</citedby><cites>FETCH-LOGICAL-c4521-a2658329b5d7a7f4efc5e006f04bbdd2a5ab38f441ce856d2e3b4eeded5730aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fsji.12061$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fsji.12061$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23672430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lappegård, K. T.</creatorcontrib><creatorcontrib>Hovland, A.</creatorcontrib><creatorcontrib>Pop, G. A. M.</creatorcontrib><creatorcontrib>Mollnes, T. E.</creatorcontrib><title>Atrial Fibrillation: Inflammation in Disguise?</title><title>Scandinavian journal of immunology</title><addtitle>Scand J Immunol</addtitle><description>Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and thrombo‐embolism. Over the past years, there has been increasing interest in the role of inflammatory processes in atrial fibrillation, from the first occurrence of the arrhythmia to dreaded complications such as strokes or peripheral emboli. As the standard drug combination which aims at rate control and anticoagulation only offers partial protection against complications, newer agents are needed to optimize treatment. In this paper, we review recent knowledge regarding the impact of inflammation on the occurrence, recurrence, perpetuation and complications of the arrhythmia, as well as the role of anti‐inflammatory therapies in the treatment for the disease.</description><subject>Animals</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anticoagulants - therapeutic use</subject><subject>Arrhythmias, Cardiac - drug therapy</subject><subject>Arrhythmias, Cardiac - etiology</subject><subject>Arrhythmias, Cardiac - physiopathology</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - etiology</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Stroke - drug therapy</subject><subject>Stroke - etiology</subject><subject>Stroke - physiopathology</subject><subject>Thromboembolism - drug therapy</subject><subject>Thromboembolism - etiology</subject><subject>Thromboembolism - physiopathology</subject><issn>0300-9475</issn><issn>1365-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0MtKAzEUBuAgiq3VhS8gA250MW2Sk8uMGynVaqXgQl2HzExGUuaiSQfp2xs71YUgmM0h8PFzzo_QKcFjEt7Er-yYUCzIHhoSEDwGnMA-GmLAOE6Z5AN05P0KYwJUwiEaUBCSMsBDNJ6undVVNLeZs1Wl17ZtrqJFU1a6rre_yDbRjfWvnfXm-hgdlLry5mQ3R-hlfvs8u4-Xj3eL2XQZ54xTEmsqeAI0zXghtSyZKXNuMBYlZllWFFRznUFSMkZyk3BRUAMZM6YwBZeAtYYRuuhz31z73hm_VrX1uQkLNqbtvCKMpCBpItL_UCKAA6WBnv-iq7ZzTTgkKCoTnpKEB3XZq9y13jtTqjdna-02imD11bcKfatt38Ge7RK7rDbFj_wuOIBJDz5sZTZ_J6mnh0Uf-QnHKIdJ</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Lappegård, K. T.</creator><creator>Hovland, A.</creator><creator>Pop, G. A. M.</creator><creator>Mollnes, T. E.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>Atrial Fibrillation: Inflammation in Disguise?</title><author>Lappegård, K. T. ; Hovland, A. ; Pop, G. A. M. ; Mollnes, T. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4521-a2658329b5d7a7f4efc5e006f04bbdd2a5ab38f441ce856d2e3b4eeded5730aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anticoagulants - therapeutic use</topic><topic>Arrhythmias, Cardiac - drug therapy</topic><topic>Arrhythmias, Cardiac - etiology</topic><topic>Arrhythmias, Cardiac - physiopathology</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - etiology</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Stroke - drug therapy</topic><topic>Stroke - etiology</topic><topic>Stroke - physiopathology</topic><topic>Thromboembolism - drug therapy</topic><topic>Thromboembolism - etiology</topic><topic>Thromboembolism - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lappegård, K. T.</creatorcontrib><creatorcontrib>Hovland, A.</creatorcontrib><creatorcontrib>Pop, G. A. M.</creatorcontrib><creatorcontrib>Mollnes, T. E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lappegård, K. T.</au><au>Hovland, A.</au><au>Pop, G. A. M.</au><au>Mollnes, T. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atrial Fibrillation: Inflammation in Disguise?</atitle><jtitle>Scandinavian journal of immunology</jtitle><addtitle>Scand J Immunol</addtitle><date>2013-08</date><risdate>2013</risdate><volume>78</volume><issue>2</issue><spage>112</spage><epage>119</epage><pages>112-119</pages><issn>0300-9475</issn><eissn>1365-3083</eissn><abstract>Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and thrombo‐embolism. Over the past years, there has been increasing interest in the role of inflammatory processes in atrial fibrillation, from the first occurrence of the arrhythmia to dreaded complications such as strokes or peripheral emboli. As the standard drug combination which aims at rate control and anticoagulation only offers partial protection against complications, newer agents are needed to optimize treatment. In this paper, we review recent knowledge regarding the impact of inflammation on the occurrence, recurrence, perpetuation and complications of the arrhythmia, as well as the role of anti‐inflammatory therapies in the treatment for the disease.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>23672430</pmid><doi>10.1111/sji.12061</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-9475 |
| ispartof | Scandinavian journal of immunology, 2013-08, Vol.78 (2), p.112-119 |
| issn | 0300-9475 1365-3083 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1419372869 |
| source | MEDLINE; Wiley Free Content; IngentaConnect Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals |
| subjects | Animals Anti-Arrhythmia Agents - therapeutic use Anti-Inflammatory Agents - therapeutic use Anticoagulants - therapeutic use Arrhythmias, Cardiac - drug therapy Arrhythmias, Cardiac - etiology Arrhythmias, Cardiac - physiopathology Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Atrial Fibrillation - physiopathology Heart Failure - drug therapy Heart Failure - etiology Heart Failure - physiopathology Humans Inflammation - drug therapy Stroke - drug therapy Stroke - etiology Stroke - physiopathology Thromboembolism - drug therapy Thromboembolism - etiology Thromboembolism - physiopathology |
| title | Atrial Fibrillation: Inflammation in Disguise? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A03%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atrial%20Fibrillation:%20Inflammation%20in%20Disguise?&rft.jtitle=Scandinavian%20journal%20of%20immunology&rft.au=Lappeg%C3%A5rd,%20K.%20T.&rft.date=2013-08&rft.volume=78&rft.issue=2&rft.spage=112&rft.epage=119&rft.pages=112-119&rft.issn=0300-9475&rft.eissn=1365-3083&rft_id=info:doi/10.1111/sji.12061&rft_dat=%3Cproquest_cross%3E1411635322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1427859185&rft_id=info:pmid/23672430&rfr_iscdi=true |